Logo Icon
OrthoLength Pro Clinical & Patient Community
Log in Register
MEDICAL DISCLAIMER: The information provided on OrthoLength Pro is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified orthopedic surgeon.
Fact Checked by Clinical Team Study Summary

Children’s Lower Limb Deformities: A Complete Patient Guide to HRQL & Treatment Options

H.
H. Chhina, A. Klassen, J. Kope...
April 01, 2021
0 views
View on PubMed
7 min read 1,293 words children lower limb deformities Medically Reviewed

Overview

Children with lower limb deformities face a unique blend of physical, emotional, and social challenges that can affect every aspect of daily life. A recent international qualitative study explored what matters most to these youngsters and their families, laying the groundwork for a new PROM that captures health‑related quality of life (HRQL) in this population. Understanding the lived experience of the child—not just the radiographic correction—helps clinicians and families make more informed treatment decisions.

The study interviewed 79 participants (children and parents) across five continents, revealing five overarching themes: appearance, physical health, psychological health, school life, and social health. These insights are now being used to create outcome scales that go beyond traditional complication rates or limb length measurements.

What This Study Examined for Children with Lower Limb Deformities

The researchers conducted semi‑structured, face‑to‑face interviews to learn how lower limb deformities influence a child’s sense of self, mobility, participation in school, and relationships with peers. By listening directly to patients and caregivers, the team identified the domains that should be measured when evaluating any surgical or non‑surgical intervention.

Why This Matters for Children with Lower Limb Deformities

Most existing data focus on technical outcomes—how much length was gained, or the rate of infection after external fixation. This study shifts the focus to what families truly care about: how the child feels about his or her appearance, how pain or fatigue limits activities, and whether the child can engage fully in school and social events. Incorporating these patient‑centered outcomes into clinical practice empowers families to choose the treatment that aligns best with their goals.

Medical Background

Lower limb deformities encompass a spectrum of conditions, including leg length discrepancy, congenital or acquired lower limb deficiency, and angular or rotational abnormalities of the hip, knee, ankle, or foot. These disorders may stem from genetic syndromes, growth‑plate disturbances, traumatic injuries, or infection. The result is often an uneven gait, chronic pain, and reduced participation in age‑appropriate activities.

How the Procedure Works

When surgical correction is indicated, the most common techniques are distraction osteogenesis (also called callotasis) and reconstruction with an intramedullary nail. In distraction osteogenesis, the surgeon performs an osteotomy, then attaches an external frame (often a circular external fixator) or a motorized intramedullary nail. The device slowly separates the bone segments (typically 1 mm per day), prompting new bone formation—a process known as bone regeneration. The lengthening phase is followed by a consolidation period during which the new bone matures.

Who Is a Candidate?

Candidates are usually children whose discrepancy exceeds 2 cm, or who have functional limitation due to angular/rotational deformities that cannot be corrected with simple bracing or shoe lifts. Ideal candidates have sufficient growth potential, good overall health, and a supportive family willing to adhere to the rigorous rehabilitation protocol that accompanies limb lengthening or reconstruction.

Clinical Summary

  • Procedure: Distraction osteogenesis (external fixator or motorized intramedullary nail) or reconstructive osteotomy with fixation.
  • Typical Duration: Lengthening phase 3‑6 months (depends on amount of length needed); total treatment up to 12‑18 months including consolidation.
  • Recovery: Intensive physiotherapy; weight‑bearing as tolerated; regular clinic visits for device adjustments.
  • Success Rate (general): 80‑95 % achieve intended length/shape with acceptable functional outcome; complication rates vary (see section below).

Study Methodology

The investigation was a qualitative, multi‑center study conducted at five sites: two in Canada, one in Ethiopia, one in India, and one in the United States. Researchers used semi‑structured interview guides to explore the lived experience of children aged 6‑18 years with lower limb deformities and their parents.

Patient Selection Criteria

Participants were selected if they (1) had a diagnosed lower limb length discrepancy or angular/rotational deformity, (2) were between 6 and 18 years old, and (3) were either awaiting, undergoing, or had completed surgical correction within the past two years. Both surgical and non‑surgical cohorts were included to capture a broad range of perspectives.

Outcome Measures

Rather than traditional clinical endpoints, the study focused on thematic analysis of interview transcripts. The emergent themes formed a conceptual framework that will be operationalized into a new PROM specific to this population.

Results & Findings

Seventy‑nine interviews yielded five major themes that together represent the domains of HRQL most important to children with lower limb deformities.

Key Outcomes

  • Appearance: Concerns about limb shape, scar visibility, and footwear choices heavily influenced self‑esteem.
  • Physical Health: Pain, fatigue, and limited endurance were recurrent statements, especially during school activities and sports.
  • Psychological Health: Anxiety about surgery, fear of bullying, and feelings of “being different” emerged across all sites.
  • School: Difficulty concentrating, need for bathroom breaks, and challenges participating in physical education were frequently reported.
  • Social Health:
  • Reduced participation in peer groups, avoidance of extracurricular activities, and a desire for acceptance were central social themes.

Complications & Risks

The qualitative study itself did not record surgical complications because its focus was on patient‑reported quality of life. However, the authors acknowledge that any future use of the PROM should be paired with conventional safety data. Known risks of distraction osteogenesis and reconstructive surgery—such as pin‑site infection, joint stiffness, nerve irritation, delayed bone healing, and, rarely, premature consolidation—must still be discussed with families.

Key Takeaways for Patients

  • Understanding how a deformity affects appearance, pain, school, and friendships is as important as measuring the amount of length gained.
  • The new PROM will let you track improvements in daily life, not just radiographic outcomes.
  • Ask your surgeon how the planned procedure will impact each of the five themes identified in the study.
  • Inquire about the rehabilitation plan: frequency of physiotherapy, expected weight‑bearing status, and timeline for returning to school and sports.
  • Discuss potential complications openly; knowing the signs of pin‑site infection or nerve irritation can help catch problems early.
  • Consider psychosocial support—counseling or peer groups—especially if anxiety or bullying are concerns.
  • Ensure that your child’s voice is heard throughout the decision‑making process; the PROM is designed to capture the child’s perspective directly.

Frequently Asked Questions

What is a patient‑reported outcome measure (PROM) and why does it matter?
A PROM is a questionnaire completed by the patient (or parent) that captures how a condition or its treatment affects daily life. It matters because it provides insight into pain, function, and emotional wellbeing that imaging alone cannot show (Source: PubMed / Europe PMC).
How does distraction osteogenesis differ from a simple leg‑lengthening surgery?
Distraction osteogenesis gradually separates bone segments using a device, allowing new bone to form in the gap. Traditional lengthening often refers to the same process but may use a fixed external frame; the key difference is the controlled, incremental nature of the stretch.
What are the most common complications after external‑fixator limb lengthening?
Pin‑site infection, joint stiffness, and transient nerve irritation are the most frequently reported issues. Most infections are superficial and respond to antibiotics, while stiffness may require additional physiotherapy.
Will my child be able to return to school and sports during treatment?
Most children resume classroom activities within weeks, but sports participation typically waits until the consolidation phase is complete—often 3‑6 months after the lengthening phase ends. Your surgeon can give a personalized timeline.
How can I help my child cope with the emotional impact of a lower limb deformity?
Open communication, involvement in support groups, and professional counseling have been shown to improve psychological health. The study highlighted the importance of addressing appearance‑related anxiety and peer acceptance early on.
More on: children lower limb deformities Last reviewed: August 15, 2026

Community Disclaimer

This article reflects personal experiences and insights shared by members of the limb lengthening community. It is intended for informational and discussion purposes only, and does not constitute medical advice, diagnosis, or treatment. Individual experiences may vary. Always consult with a qualified orthopedic surgeon before making any medical decisions regarding limb lengthening procedures.

Explore Related Research

Clinical Insight

Trochanteric-Entry Intramedullary Lengthening Nails in Growing Children: Safety Profile and Clinical Implications

Overview Limb lengthening, also known as distraction osteogenesis, is a surgical procedure used to treat limb length discrepancies. One common method of limb lengthening is through the use of intramedullary nails, such as the Precice™ nail. Recently, a study examined the safety of trochanteric-entry intramedullary lengthening nails in skeletally immature patients (Source: PubMed). This study is significant because it sheds light on the potential risks and benefits of this procedure in younger patients. The study focused on patients with more than 2 years of growth remaining, which is crucial because this population is at a higher risk of proximal femoral growth disturbance, including coxa valga. The researchers aimed to evaluate the proximal femoral morphology following trochanteric-entry intramedullary lengthening in these patients. The findings of this study are essential for patients, parents, and healthcare providers who are considering this procedure. What This Study Examined The study examined the safety of trochanteric-entry intramedullary lengthening nails in skeletally immature patients. Specifically, it looked at the radiographic parameters, including the NSA, mLPFA, and ATD, before and after the procedure. Why This Matters for Patients This study matters for patients because it provides insight into the potential risks and benefits of trochanteric-entry intramedullary lengthening nails. The results can help patients and their families make informed decisions about their treatment options. Additionally, the study's findings can inform healthcare providers about the best practices for this procedure and how to minimize potential complications. Medical Background Limb lengthening is a surgical procedure that involves cutting and slowly lengthening the bone to treat limb length discrepancies. This can be achieved through various methods, including external fixation, internal lengthening nails, or a combination of both. The Precice™ nail is an example of an intramedullary nail used for femoral lengthening. How the Procedure Works The procedure involves inserting an intramedullary nail into the femur (thigh bone) through an incision in the hip. The nail is then lengthened over time using an external controller, which gradually separates the bone segments. This process, known as distraction osteogenesis, allows for new bone growth and lengthening of the limb. Who Is a Candidate? Candidates for limb lengthening surgery typically have a significant limb length discrepancy, which can be congenital or acquired due to injury or illness. The procedure is often performed on patients with conditions such as achondroplasia, fibular hemimelia, or CPT. In growing children, the timing of surgery must consider remaining growth potential, hormonal status, and the risk of growth‑plate disturbance. Clinical Summary Procedure: Trochanteric-entry intramedullary lengthening nail insertion Typical Duration: Several months to several years, depending on the lengthening required Recovery: Varied, but typically involves a period of partial weight‑bearing and physical therapy Success Rate (general): High, but depends on individual patient factors and the expertise of the healthcare provider Study Methodology The study was a retrospective, institutional review board‑approved case series conducted at a single tertiary pediatric orthopedic center. Inclusion criteria were: Skeletally immature patients (open physes) with at least 2 years of growth remaining as estimated by the Green‑Anderson growth‑remaining chart. Underwent antegrade femoral lengthening with a Precice™ magnetically driven nail between January 2017 and December 2024. Minimum postoperative radiographic follow‑up of 12 months. Patients with prior femoral pathology, infection, or previous hip surgery were excluded. All surgeries utilized a standard trochanteric entry point, positioned at the lateral aspect of the greater trochanter. The nail was inserted under fluoroscopic guidance, and the lengthening protocol was programmed to achieve 1 mm of distraction per day after a 7‑day latency period. Radiographic assessments were performed pre‑operatively, immediately post‑operatively, and at final follow‑up. The primary outcomes included changes in: Neck‑shaft angle (NSA) – measured on an anteroposterior pelvis radiograph. Mechanical lateral proximal femoral angle (mLPFA) – the angle between the mechanical femoral axis and the proximal femoral line. Articulotrochanteric distance (ATD) – the vertical distance from the femoral head centre to the tip of the greater trochanter. Clinically meaningful coxa valga was defined as an increase in NSA of ≥2 standard deviations (≈ 5°) from baseline. Linear regression analyses evaluated the relationship between remaining growth (years until predicted skeletal maturity) and postoperative changes in the measured parameters. Statistical analysis employed SPSS® version 28.0. Continuous variables are reported as mean ± standard deviation; categorical variables as counts and percentages. A p‑value 2 years of growth remaining, with a low incidence of proximal femoral growth disturbance. Clinical Implications These findings have several practical ramifications for orthopedic surgeons, patients, and families: Safety in the majority of growing children: For patients with at least two years of anticipated growth, the risk of clinically significant coxa valga or other proximal femoral deformities appears minimal. Age‑specific risk stratification: Children younger than 9 years, particularly those with >4 years of growth remaining, may warrant closer radiographic monitoring because the study identified a trend toward valgus change proportional to remaining growth. Surveillance protocol: A reasonable follow‑up schedule includes radiographs at 3, 6, 12, and 24 months post‑operation, with additional imaging if the patient reports hip pain or demonstrates gait changes. Counselling for families: When discussing treatment options, clinicians can reassure families that infection and osteonecrosis were not observed in this series, but they should also explain the small possibility of valgus progression, especially in very young patients. Decision‑making for timing of surgery: In cases where the discrepancy is modest and the child is very young, clinicians may consider delaying definitive lengthening until closer to skeletal maturity, using alternative methods (e.g., temporary external fixation) in the interim. Ultimately, the study supports the continued use of trochanteric-entry intramedullary nails as a reliable option for limb lengthening in skeletally immature patients, provided that a structured radiographic surveillance plan is in place. Frequently Asked Questions Q: What is coxa valga and why is it a concern after femoral lengthening? A: Coxa valga refers to an increased neck‑shaft angle of the femur, which can alter hip biomechanics, potentially leading to gait abnormalities, accelerated joint wear, or increased risk of hip dislocation. Monitoring the NSA after lengthening helps detect early valgus changes. Q: How does a trochanteric‑entry nail differ from a retrograde or lateral entry nail? A: Trochanteric entry involves inserting the nail through the greater trochanter, preserving the distal femoral physis and allowing a more natural lengthening vector. Retrograde nails are placed from the distal femur and risk injury to the distal growth plate, while lateral entry can be more technically demanding in small children. Q: Are there specific activities that should be avoided after surgery? A: Patients are typically instructed to avoid high‑impact sports (e.g., running, jumping) for the first 6‑12 weeks, adhere to weight‑bearing restrictions set by the surgeon, and engage in a supervised physical‑therapy program to maintain joint range of motion. Q: What signs would indicate a need for earlier radiographic evaluation? A: New onset hip or groin pain, noticeable limp, asymmetry in limb length, or any change in gait symmetry should prompt an earlier X‑ray to assess for unexpected proximal femoral changes. Q: If a child develops progressive coxa valga, what are the treatment options? A: Mild valga may be managed with observation if functional outcomes are acceptable. More pronounced deformities can be addressed surgically with guided growth (temporary hemiepiphysiodesis) or corrective osteotomy, depending on severity and the child's remaining growth. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

Limb Lengthening Guide

Overview Limb lengthening, also known as distraction osteogenesis, is a surgical procedure used to treat limb length discrepancy. This condition can be caused by a variety of factors, including congenital defects, trauma, or infections. The use of intramedullary nails or external fixators is a crucial aspect of this procedure, as it allows for the gradual lengthening of the bone while maintaining stability and promoting bone regeneration. The study examined the effectiveness of using elastic intramedullary reinforcement in combination with external fixation devices for lower limb lengthening. This technique has several advantages, including the ability to exclude injury to the growth plates in children and the ability to provide high precision of limb reconstruction (Source: PubMed / Europe PMC). What This Study Examined This study compared the outcomes of patients who underwent lower limb lengthening using titanium rods with composite calcium phosphate coating versus those who used uncoated rods. The study included 65 patients with a mean age of 12.6 years, who underwent either femoral lengthening, monofocal tibial lengthening, or bifocal tibial lengthening. Why This Matters for Patients Understanding the effectiveness of different techniques and materials used in limb lengthening is crucial for patients who are considering this procedure. The use of elastic intramedullary reinforcement can enhance the mechanical strength of the lengthened bone and improve outcomes. However, it is essential to weigh the benefits and risks of each approach and to discuss individual concerns with a qualified orthopedic surgeon. Medical Background Limb lengthening is a complex procedure that involves the use of various techniques and materials to gradually increase the length of a bone. The process typically begins with an osteotomy, which is followed by the placement of an external fixator or intramedullary nail. The bone is then gradually lengthened through a process called callotasis, which involves the slow and controlled distraction of the bone segments. How the Procedure Works The procedure typically involves several stages, including the initial surgery, the lengthening phase, and the consolidation phase. During the lengthening phase, the patient will need to attend regular follow-up appointments with their orthopedic surgeon to adjust the external fixator or intramedullary nail and to monitor the progress of the bone lengthening. The consolidation phase typically lasts several months, during which time the new bone tissue is allowed to mature and strengthen. Who Is a Candidate? Limb lengthening is typically recommended for patients who have a significant limb length discrepancy that is causing discomfort, pain, or difficulties with mobility. The ideal candidate for this procedure is typically a patient who is motivated and able to comply with the post-operative instructions and follow-up appointments. The procedure can be performed on patients of all ages, although the specific technique and materials used may vary depending on the individual patient's needs and circumstances. Clinical Summary Procedure: Limb lengthening using intramedullary nails or external fixators Typical Duration: Several months to several years, depending on the individual patient's needs and circumstances Recovery: The recovery process typically involves several stages, including the initial surgery, the lengthening phase, and the consolidation phase Success Rate (general): The success rate of limb lengthening varies depending on the individual patient's needs and circumstances, although the procedure is generally considered to be highly effective in correcting limb length discrepancy Study Methodology The study was conducted at the Ilizarov National Medical Research Center for Traumatology and Orthopedics between 2017 and 2020. The study included 65 patients with a mean age of 12.6 years, who underwent either femoral lengthening, monofocal tibial lengthening, or bifocal tibial lengthening. The patients were followed up for 12 months after the removal of the external fixation device. Patient Selection Criteria The study included patients who had congenital limb shortening that was not associated with pathological bone formation. The patients were selected based on their medical history, physical examination, and radiographic evaluation. Outcome Measures The study evaluated the outcomes of the patients based on the external fixation index, which is a measure of the time it takes for the bone to heal and mature. The study also evaluated the incidence of complications, such as deformity or fracture, and the need for unplanned surgical interventions. Results & Findings The study found that there was no significant difference in the external fixation index between the patients who used titanium rods with composite calcium phosphate coating and those who used uncoated rods. The study also found that the diameter of the intramedullary rods was a key factor in preventing deformity or fracture after limb lengthening. Key Outcomes The study found that the use of elastic intramedullary reinforcement in combination with external fixation devices was effective in achieving limb lengthening in patients with congenital limb shortening. The study also found that the incidence of complications, such as deformity or fracture, was low. Complications & Risks The study found that there were three cases of deformity or fracture that required unplanned surgical interventions, as well as one case of fracture of the regenerate bone at the junction of the intramedullary rods. These complications highlight the importance of careful patient selection, precise surgical technique, and close follow-up care to minimize the risk of adverse outcomes. Key Takeaways for Patients The use of elastic intramedullary reinforcement in combination with external fixation devices is a effective technique for achieving limb lengthening in patients with congenital limb shortening. The diameter of the intramedullary rods is a key factor in preventing deformity or fracture after limb lengthening. PATIENTS SHOULD ASK THEIR SURGEON ABOUT THE TYPE OF INTRAMEDULLARY RODS USED AND THE DIAMETER OF THE RODS TO MINIMIZE THE RISK OF COMPLICATIONS. Frequently Asked Questions What is limb lengthening? Limb lengthening, also known as distraction osteogenesis, is a surgical procedure used to treat limb length discrepancy. The procedure involves the use of various techniques and materials to gradually increase the length of a bone. What are the benefits of using elastic intramedullary reinforcement in limb lengthening? The use of elastic intramedullary reinforcement in combination with external fixation devices offers several advantages, including the ability to exclude injury to the growth plates in children and the ability to provide high precision of limb reconstruction. What are the risks and complications of limb lengthening? The risks and complications of limb lengthening include deformity, fracture, and fracture of the regenerate bone. These complications can be minimized by careful patient selection, precise surgical technique, and close follow-up care. How long does the limb lengthening procedure take? The limb lengthening procedure typically takes several months to several years to complete, depending on the individual patient's needs and circumstances. The procedure involves several stages, including the initial surgery, the lengthening phase, and the consolidation phase. What is the success rate of limb lengthening? The success rate of limb lengthening varies depending on the individual patient's needs and circumstances, although the procedure is generally considered to be highly effective in correcting limb length discrepancy. Related Articles A Comprehensive Guide to Humeral Lengthening in Achondroplasia: Patient Perspectives and Treatment Outcomes Revolutionizing Achondroplasia Treatment: Understanding Vosoritide Therapy A Comprehensive Guide to Limb Lengthening in Achondroplasia: Understanding the Costs, Benefits, and Risks The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Read Full Summary →
Clinical Insight

The Impact of Type 1 Diabetes Mellitus on Growth Patterns in Saudi Children and Adolescents: A Comprehensive Guide

Overview Type 1 Diabetes Mellitus (T1DM) is a chronic autoimmune condition that affects the body's ability to produce insulin, a hormone essential for regulating blood sugar levels. The impact of T1DM on growth and development in children and adolescents has been a topic of interest for many years, with some studies suggesting that the condition may affect linear growth and increase the risk of short stature. A recent retrospective cross-sectional study conducted in Saudi Arabia aimed to assess 1 and identify factors independently associated with short stature among Saudi school-age children and adolescents with T1DM, compared to a healthy control group. The study's purpose was to investigate the relationship between T1DM and growth patterns in children and adolescents, with a focus on the roles of glycemic control, disease duration, and nutritional factors. The findings of this study have important implications for the management and care of children and adolescents with T1DM, highlighting the need for systematic longitudinal growth monitoring and early identification of those at highest risk of growth impairment. Medical Background T1DM is a complex condition that requires careful management to prevent complications and ensure optimal growth and development. The condition is characterized by the autoimmune destruction of pancreatic beta cells, leading to a deficiency in insulin production. As a result, individuals with T1DM require exogenous insulin therapy to regulate their blood sugar levels. Glycemic control is a critical aspect of T1DM management, as poor control can lead to a range of complications, including microvascular and macrovascular disease, nephropathy, retinopathy, and neuropathy. Additionally, poor glycemic control has been linked to growth impairment and short stature in children and adolescents with T1DM. Linear growth is a complex process that involves the coordinated action of multiple hormones, including growth hormone, insulin-like growth factor-1 (IGF-1), and thyroid hormone. In children and adolescents with T1DM, growth impairment may occur due to a range of factors, including poor glycemic control, insulin deficiency, and nutritional deficiencies. Short stature is defined as a height below the third percentile for age and gender, and it can have significant psychological and social implications for affected individuals. In the context of T1DM, short stature may be associated with a range of factors, including disease duration, glycemic control, and nutritional status. Key Takeaways Children and adolescents with T1DM have a higher prevalence of short stature compared to their healthy peers. Disease duration is a strong, independent predictor of short stature in T1DM, with progressively higher risk as disease duration lengthens. Intermediate and long-standing disease duration are significant independent predictors of short stature, regardless of glycemic control status. Glycemic control, vitamin D status, time in range, and treatment adherence are not significantly associated with short stature after adjustment. Systematic longitudinal growth monitoring is essential for early identification and intervention in patients with T1DM, particularly those with disease duration exceeding five years. Methodology The study was conducted at an endocrinology clinic in Saudi Arabia and included 250 patients with T1DM aged 5-18 years, as well as 267 healthy controls. The patients with T1DM were matched to the healthy controls using propensity score matching, resulting in a final sample of 231 matched pairs. Data were extracted from electronic medical records using a standardized form, and anthropometric measurements were converted to Z-scores and percentiles using validated Saudi growth charts. Short stature was defined as a height below the third percentile for age and gender. Univariate and multivariable logistic regression analyses were performed to identify factors associated with short stature among T1DM participants. The results of the study provide valuable insights into the relationship between T1DM and growth patterns in children and adolescents. Results & Complications The study found that the median age of the T1DM participants was 13.0 years, with a slight male predominance (58.0%). The proportion of short stature was significantly higher in the T1DM group compared to the control group (6.1% vs. 1.7%, p = 0.016). The study also found that the proportion of short stature increased progressively with diabetes duration, with 3.0% of patients with new-onset disease, 14.9% with intermediate duration (2-5 years), and 25.0% with long-standing disease (>5 years) having short stature (p = 0.001). Age at onset of T1DM was also significantly associated with having short stature (p = 0.036). In multivariable analysis, intermediate and long-standing disease duration remained significant independent predictors of short stature, regardless of glycemic control status. The study's findings highlight the importance of early identification and intervention in patients with T1DM, particularly those with disease duration exceeding five years. The results also underscore the need for systematic longitudinal growth monitoring and tailored management strategies to optimize growth and development in children and adolescents with T1DM. FAQ Q: What is the impact of T1DM on growth and development in children and adolescents? A: T1DM can affect linear growth and increase the risk of short stature in children and adolescents, particularly those with poor glycemic control and long-standing disease duration. Q: What are the key factors associated with short stature in T1DM? A: Disease duration, intermediate and long-standing disease duration, and age at onset of T1DM are significant independent predictors of short stature in T1DM. Q: How can growth impairment be prevented or managed in children and adolescents with T1DM? A: Systematic longitudinal growth monitoring, optimized glycemic control, and tailored management strategies can help prevent or manage growth impairment in children and adolescents with T1DM. Q: What are the psychological and social implications of short stature in children and adolescents with T1DM? A: Short stature can have significant psychological and social implications for affected individuals, including decreased self-esteem, social withdrawal, and decreased quality of life.

Read Full Summary →